Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype | Journal of Proteome Research
Vaccines | Free Full-Text | A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants
Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses - ScienceDirect
Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans | Science Translational Medicine
IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases
Vaccines | Free Full-Text | Efficacy of Six Different SARS-CoV-2 Vaccines during a Six-Month Follow-Up and Five COVID-19 Waves in Brazil and Mexico
Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines | Nature Communications
Demystifying Serum Free Light Chains – a guide for primary care - Manchester University NHS Foundation Trust
Immunoglobulin germline gene variation and its impact on human disease | Genes & Immunity
Light Chain Myeloma: Symptoms, Treatment, Outlook, More
Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype | Journal of Proteome Research
Convergent antibody evolution and clonotype expansion following influenza virus vaccination | PLOS ONE
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination | npj Vaccines
Beckman Coulter · Diazyme Human Kappa & Lambda FLC assays • healthcare-in-europe.com
Frontiers | Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
Vaccines | Free Full-Text | Exigency of Plant-Based Vaccine against COVID-19 Emergence as Pandemic Preparedness
Vaccines | Free Full-Text | Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness
Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum | NEJM
Frontiers | Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy
Severe breakthrough COVID-19 with a heavily mutated variant in a multiple myeloma patient 10 weeks after vaccination - ScienceDirect
Differences in nasal immunoglobulin A responses to influenza vaccine strains after live attenuated influenza vaccine (LAIV) immunization in children - Turner - 2020 - Clinical & Experimental Immunology - Wiley Online Library
Real-world effectiveness of the mRNA-1273 vaccine against COVID-19: Interim results from a prospective observational cohort study - The Lancet Regional Health – Americas
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination | npj Vaccines
A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination | Nature Medicine
Frontiers | Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants
COVID-19 Vaccination and Glomerulonephritis - ScienceDirect
COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2 - eClinicalMedicine
